Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation by Mauler, M. et al.
February 12, 2019 Circulation. 2019;139:918–931. DOI: 10.1161/CIRCULATIONAHA.118.033942918
The full author list is available on page 
930.
*I.H. and D.D. contributed equally to 
this work (see page 930).
Key Words: blood platelets  
◼ inflammation ◼ integrins  
◼ neutrophils ◼ reperfusion injury  
◼ reactive oxygen species ◼ serotonin
Sources of Funding, see page 930
BACKGROUND: Platelets store large amounts of serotonin that they 
release during thrombus formation or acute inflammation. This facilitates 
hemostasis and modulates the inflammatory response.
METHODS: Infarct size, heart function, and inflammatory cell 
composition were analyzed in mouse models of myocardial reperfusion 
injury with genetic and pharmacological depletion of platelet serotonin. 
These studies were complemented by in vitro serotonin stimulation assays 
of platelets and leukocytes in mice and men, and by measuring plasma 
serotonin levels and leukocyte activation in patients with acute coronary 
syndrome.
RESULTS: Platelet-derived serotonin induced neutrophil degranulation 
with release of myeloperoxidase and hydrogen peroxide (H2O2) 
and increased expression of membrane-bound leukocyte adhesion 
molecule CD11b, leading to enhanced inflammation in the infarct area 
and reduced myocardial salvage. In patients hospitalized with acute 
coronary syndrome, plasmatic serotonin levels correlated with CD11b 
expression on neutrophils and myeloperoxidase plasma levels. Long-
term serotonin reuptake inhibition—reported to protect patients with 
depression from cardiovascular events—resulted in the depletion of 
platelet serotonin stores in mice. These mice displayed a reduction in 
neutrophil degranulation and preserved cardiac function. In line, patients 
with depression using serotonin reuptake inhibition, presented with 
suppressed levels of CD11b surface expression on neutrophils and lower 
myeloperoxidase levels in blood.
CONCLUSIONS: Taken together, we identify serotonin as a potent 
therapeutic target in neutrophil-dependent thromboinflammation during 
myocardial reperfusion injury.
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Immediate restoration of blood flow by coronary in-tervention improves the survival of patients with myocardial infarction (MI). Targeting the deleterious 
processes during subsequent reperfusion injury holds 
the promise of further reducing the final infarct size 
and hence limiting heart failure in survivors.1 The initial 
phase of reperfusion is characterized by ionic imbalance 
and distortion of the Na+/Ca2+ and Na+/H+ exchangers, 
leading to mitochondrial damage and hypercontraction 
of the myocardium.2,3 Microembolization, production 
of reactive oxygen species, and instability of vessel wall 
integrity further threaten myocardial recovery.4 Finally, 
excessive leukocyte recruitment into the affected myo-
cardium occurs in the early hours after reperfusion (neu-
trophils are the predominant invaders during the first 24 
hours).5 The effect of neutrophil infiltration on outcome 
appears to follow a U-shaped curve with an optimum of 
modest neutrophil recruitment benefiting postinfarction 
healing, while excessive infiltration is detrimental, be-
cause neutrophils aggravate reperfusion injury.6
Mitigating the excess of neutrophil infiltration may 
restrict reperfusion injury while maintaining the benefi-
cial healing process.
For transmigration through the vessel wall into in-
flamed tissues, neutrophils interact with activated 
endothelial cells directly7 or under the influence of 
platelet-mediated cell–cell communication.8 Endothe-
lial selectins mediate neutrophil tethering and rolling, 
followed by integrin-mediated firm cell adhesion that 
allows for subsequent transmigration.9 Interfering with 
selectin and integrin function reduced experimental 
myocardial reperfusion injury, illustrating the relevance 
of inflammatory cell recruitment and the potential of 
pharmacological intervention.10
We recently reported that platelet-derived serotonin 
(5-hydroxytryptamine, 5-HT) enhanced the recruitment 
of neutrophils to sites of acute inflammation and tissue 
damage.11 However, the underlying mechanism remained 
elusive. In the context of MI and coronary intervention, 
observational studies proposed that the depletion of 
platelet serotonin stores by long-term administration of 
serotonin reuptake inhibitors (a side-effect of many anti-
depressants) may improve outcome after MI and vasomo-
tion post percutaneous coronary intervention (PCI).12
We hypothesized that platelet serotonin aggravates 
myocardial reperfusion injury by promoting excessive 
neutrophil recruitment.
Indeed, serotonin induced exocytosis of neutrophil 
granules, thereby increasing the surface expression 
of the β2-integrin CD11b, mediating cell adhesion to 
platelets and the endothelium, and releasing myeloper-
oxidase (MPO) and hydrogen peroxide (H2O2), which al-
together impaired healing after myocardial infarction.13
METHODS
The data, analytic methods, and study materials will be made 
available to other researchers for purposes of reproducing 
the results or replicating the procedure. All data, methods, 
materials are available on personal request at the Department 
of Cardiology and Angiology I, Heart Center, University of 
Freiburg(contact: daniel.duerschmied@universitaets-herzzen-
trum.de).
A detailed section of all used methods is available in the 
online version of this manuscript.
Animals
Ten to 12-week-old tryptophan hydroxylase-1-deficient 
(Tph1−/−) mice were kindly provided by Michael Bader from 
the Max-Delbrück-Center for Molecular Medicine (Berlin, 
Germany). Wild type (WT) littermates of heterozygous breed-
ing were on a C57BL/6 N background. All mice were housed 
in the local animal facility. All experiments were conducted 
strictly according to the German animal protection law and 
in accordance with good animal practice as defined by the 
Federation of Laboratory Animal Science Associations (www.
felasa.eu) and the national animal welfare body GV-SOLAS 
(www.gv-solas.de). The examinations undertaken in this 
study were approved by the federal authorities in Freiburg 
and the Institutional Review Board.
Murine Model of Myocardial Ischemia 
Reperfusion
All surgeries were performed between 10 am and 2 pm to 
avoid circadian rhythm–associated irregularities accord-
ing to recently published guidelines for experimental mod-
els of myocardial ischemia and infarction.14 Briefly, WT and 
Clinical Perspective
What Is New?
• Markers of neutrophil degranulation correlate with 
plasmatic serotonin levels in acute coronary syn-
drome patients.
• Neutrophils express serotonin receptors 5HT4 and 
5HT7.
• Platelet-derived serotonin triggers neutrophil 
degranulation.
• Genetic or pharmacological depletion of serotonin 
in platelets protects from myocardial ischemia and 
reperfusion injury.
What Are the Clinical Implications?
• Platelet-derived serotonin stimulating neutrophil 
infiltration, degranulation, and oxidative burst 
represents a druggable target to mitigate the in-
flammatory burden in myocardial ischemia and re-
perfusion injury.
• Inhibiting serotonin uptake into platelets of patients 
treated for depression reduced neutrophil degran-
ulation even under otherwise healthy conditions, 
indicating that the platelet serotonin–neutrophil 
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Tph1−/− mice were anesthetized by intraperitonially injection 
of 80 mg/kg ketamine (Ketavet; Pfizer Pharmacia, Berlin, 
Germany) and 4,8 mg/kg xylazine (Rompun; Bayer Vital, 
Leverkusen, Germany). Analgesia was provided by subcuta-
neous injection of 125 µg/kg buprenorphine. To avoid de-
hydration, 500 µL warm 0.9% NaCl (9 mg/mL) containing 
5% glucose (G5; B.Braun Melsungen, Melsungen, Germany) 
was injected intraperitonially. Mice were placed on a heat-
ing pad to maintain body temperature at 37°C. The opera-
tion table was tilted 20% to allow visualization of the vocal 
cords and mice were intubated under sight. Ventilation was 
set to a maximal end-inspiratory pressure of 10 cm H2O, at 
a respiratory rate of 110 breaths per minute, and an inspira-
tion/expiration ratio of 1/1.5 with a small-animal respirator 
(TSE Systems, Bad Homburg, Germany). Oxygen saturation, 
heart rate, and respiratory rate were monitored throughout 
the procedure by a MouseOX system (Starr Life Sciences, 
Oakmont, Pennsylvania). Anesthesia was maintained by addi-
tion of 1.2% isoflurane (Abbott, Wiesbaden, Germany) dur-
ing surgery. After right lateral positioning of the animal, left 
lateral thoracotomy was performed and the left anterior de-
scending (LAD) coronary artery was identified. To induce is-
chemia an 8.0 nylon suture (Prolene; Ethicon, Norderstedt, 
Germany) was placed around the vessel and a loose loop was 
formed. A fine bore 0.61-mm polythene tube was placed on 
the LAD and the loop was tied. Ligation was visually con-
firmed by paling of the left ventricular anterior wall. The tube 
was removed after 30 minutes to allow reperfusion of myo-
cardium indicated by a bright red color within the LAD. After 
evacuation of the pneumothorax chest and skin wounds 
were closed using a 6-0 Prolene suture (Ethicon, Norderstedt, 
Germany). Mice were monitored until spontaneous breathing 
occurred and placed under a heating lamp. A second dose of 
buprenorphine was administered 10 hours after surgery.
Determination of Infarct Size
Hearts were excised 24 hours after surgery and placed in 
a petri dish containing 0.9% NaCl (B.Braun Melsungen, 
Melsungen, Germany) solution; the aorta was cannulated 
using a 22-gauge safety intravenous catheter with injec-
tion port (Vasofix Safety; B.Braun Melsungen, Melsungen, 
Germany) and fixated using a 6-0 Prolene suture. Ligation was 
reestablished by placing a polythene tube under the existing 
knot. Hearts were perfused with warm NaCl to remove any 
blood residues for 5 minutes by gravity flow. Then, 200 µL 5% 
MONOLITE Blue (Heubach, Langelsheim, Germany) diluted 
in 0.9% NaCl containing household detergent was injected 
into the system via a 3-way cock to visualize affected myocar-
dium. Hearts were frozen at −20°C for 10 minutes afterward 
and cut in 5 to 7 1-mm sections using a cold razor blade. 
Slices were put in phosphate buffer (0.2 mol/L Na2HPO4 / 0.2 
mol/L NaH2PO4, adjusted to pH 7.4) containing 1% triphe-
nyltetrazolium chloride (Sigma-Aldrich Chemie, Steinheim, 
Germany) and incubated in a water bath set to 37°C for 15 
minutes. Necrotic tissue appeared white and healthy myocar-
dium was stained red. Heart sections were placed on a cover 
slip, embedded with 5% agarose and covered with a second 
slip. Slices were photographed from both sides using an EOS 
1000D camera (Canon Deutschland, Krefeld, Germany) under 
a Stemi 2000-C binocular (Carl Zeiss, Oberkochen, Germany). 
Infarct size was calculated as the percentage of necrotic tissue 
in relation to nonmonolite blue area with ImageJ software.
Echocardiography
Mice were anesthetized by 2% isoflurane intransally and 
placed on a heating pad. Chest hair was removed using 
an electric shaver and animals were fixated on the back. 
Echocardiography loops were recorded in B and M modes in 
longitudinal and short axis views on a Vevo 3100 equipped 
with a MX550D transducer (both FUJIFILM VisualSonics, 
Inc., Toronto, Ontario, Canada). Mice were fixed on a heated 
table and heart rate was monitored during the procedure. 
Systole and diastole were defined based on concomitant 
electrocardiography (ECG) recordings. The end-systolic time 
point for left ventricular (LV) diameter measurement was de-
fined as the maximum of ventricle contraction just before 
complete closure of the aortic valve. End-diastole was de-
fined as the maximum of LV dilation and filling just before 
mitral valve closing (when visible) and aortic valve opening. 
LV ejection fraction (LVEF) was determined by LV tracing 
relating end systolic LV area as the minimal LV cross-sectional 
area to end-diastolic LV area as the maximum LV cross-sec-
tional area in long axis views. Fractional shortening (FS) was 
assessed from short axis M-mode using VevoLab software 
(FUJIFILM VisualSonics).
Quantitative Real-Time Polymerase Chain 
Reaction
Quantitative real-time polymerase chain reaction was per-
formed using TaqMan Fast Advanced Master Mix (Thermo 
Fisher Scientific, Braunschweig, Germany) or IQ SYBR Green 
Supermix (Bio-Rad Laboratories, München, Germany) on a 
C1000 Touch Thermal Cycler (Bio-Rad Laboratories). Samples 
were amplified using An overview of used Taqman probes 
(Table I in the online-only Data Supplement) or oligonucle-
otides (Table II in the online-only Data Supplement). Data 
were statistically analyzed using the 2−▵▵Ct method.
Flow Cytometry
Murine Blood Samples
Blood from WT ant Tph1−/− mice was obtained by cardiac 
puncture using a 30-gauge needle coated with unfraction-
ated heparin (B. Braun Melsungen, Melsungen, Germany). 
Then, 10 µL were incubated with 190 µL lysis buffer (BD 
Bioscience, Heidelberg, Germany) for 5 minutes and leuko-
cytes were counted in a Neubauer chamber. Blood was imme-
diately transferred to an Eppendorf tube containing 1.5 µg/µL 
enoxaparin (Sanofi Aventis, Frankfurt, Germany) in 50 µL PBS 
containing 0.9 mmol/L calcium, 0.5 mmol/L magnesium, and 
0.1% BSA (PBS+/+, BSA). For in vitro stimulation, blood was 
incubated with either vehicle, or 100 µmol/L 5-hydroxytryp-
tamine (5-HT, serotonin; Sigma-Aldrich CHEMIE, Steinheim, 
Germany) for 15 minutes, as previously described.15–18 Platelet 
rich plasma (PRP) was prepared as described above. Samples 
were diluted 1:6 in 37°C warm PBS. Ninety microliters diluted 
blood or PRP was mixed with 10 µL antibody mix and incu-
bated for 15 minutes in the dark at room temperature. Stained 
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warm 1X Phosflow Lyse/Fix buffer (BD Bioscience, Heidelberg, 
Germany) and incubated for 30 minutes at room tempera-
ture. Intracellular analysis was performed using Fixation/
Permeabilization Solution Kit (BD Bioscience, Heidelberg, 
Germany) according to suppliers protocol. Data were ac-
quired on a BD FACSCanto II and analyzed with FlowJo v10 
software (Tree Star, Ashland, Oregon).
To evaluate leukocyte subsets, platelet neutrophil com-
plexes, integrin, and selectin expression after 24 hours of 
reperfusion, the following antibodies were used in 1:16 di-
lution in PBS+/+, BSA: anti-CD41-PECy7 (clone MWReg30), 
anti-CD42d-PerCPCy5.5 (clone 1C2), anti-CD45.2-AmCyan 
(clone 104), anti-CD45.2-PacificBlue (clone 104), anti-
CD115-APC (clone CSF-1R), anti-F4/80-PE (clone BM8), 
anti-CD182-FITC (clone SA045E1), anti-CD3-FITC (clone 
145-2C11), anti-CD19-PECy7 (clone 1D3), anti-Ly6C-PerCP/
Cy5.5 (clone HK 1.4), anti-CD11a/CD18-PerCPCy5.5, (clone 
H155-78; all BioLegend, Fell, Germany), anti-CD62P-Paci-
ficBlue (clone RB40.34), anti-CD11b-APCCy7 (clone M1/70), 
anti-CD162-PacificBlue (clone 2PH1), anti-Ly6G-PE (clone 
1A8; all Becton Dickinson, Heidelberg, Germany), anti-GPIIb/
IIIa (clone JON/A) anti-GPVI-FITC (clone JAQ1, all EMFRET 
Analytics, Eibelstadt, Germany), anti-Ly6G(Gr1)-PECy7 (clone 
RB6-8C5) and anti-CD62L-APC (clone MEL-14; both eBios-
ceince, Frankfurt, Germany).
Human Blood Samples
Whole blood from healthy volunteers, depressed patients, 
and patients suffering from acute coronary syndrome (ACS) 
was obtained by peripheral venous puncture. Blood was 
drawn from ACS patients on the day after percutaneous in-
tervention. ACS patients and patients with depression gave 
written informed consent as approved by the Institutional 
Review Board of the University Hospital of Freiburg: 287/12, 
and 18/11_160618, respectively. In a separate experi-
ment, neutrophils of healthy volunteers were isolated from 
whole blood using Polymorphprep (Axis-Shield, Rodelokka, 
Norway) according to manufacturer’s protocol. For in vitro 
stimulation blood was incubated with either vehicle, or 100 
µmol/L 5-hydroxytryptamine for 15 minutes at room tem-
perature. For receptor blocking experiments blood was incu-
bated with 100 µmol/L of a 5-HT receptor antagonist (5HTR4: 
SB207266; 5HTR7: SB269970; both Sigma-Aldrich Chemie, 
Steinheim, Germany) before stimulation. Blood was diluted 
1:6 in warm Flow Cytometry buffer and 90 µL were stained 
with 10 µL antibody mix and incubated for 15 minutes in 
the dark at room temperature. Stained whole blood samples 
were mixed gently with 400 µL 37°C warm 1X Phosflow 
Lyse/Fix buffer (BD Bioscience, Heidelberg, Germany) and 
incubated for 30 minutes at room temperature. Data were 
acquired on a BD FACSCanto II and analyzed with FlowJo 
v10 software. Antibody mix to analyze platelet neutrophil 
complex (PNC) content, integrin, and selectin expression 
contained 1:16 dilution of the following monoclonal anti-
bodies in PBS+/+, BSA: anti-CD41-PECy7 (clone HIP8), anti-
CD45-APCCy7 (clone HI30), anti-CD66b-PerCP/Cy5.5 (clone 
G10F5), anti CD182-APC (clone 5E8/CXCR2), anti CD162-PE 
(clone KPL-1), anti-CD11a/CD18-AlexaFluor 488 (clone m24), 
anti-CD62L-BrilliantViolet 421 (clone DREG-56), anti-CD11a-
PECy7 (clone HI111), and anti-CD11b-AlexaFluor 488 (clone 
ICRF44; all BioLegend, Fell, Germany).
Statistical Analysis
Experimental results are presented as mean values±SEM. 
One-way ANOVA with post hoc Tukey multiple comparisons 
test was performed when comparing >2 groups. Two-way 
ANOVA with Bonferroni multiple comparisons testing was 
used when more than 2 groups and variables were compared. 
Repeated measures ANOVA was used when the observations 
were not independent. Paired t test was used when samples 
were split and analyzed under various conditions. Pearson 
correlation analysis, Fisher exact test, Mann–Whitney U test or 
Student t test were used as indicated. P values from multiple 
t tests were adjusted using the Holm–Sidak method. Adjusted 
P values of ≤0.05 denote significant changes. Statistics were 
calculated using GraphPad Software.
RESULTS
Platelet Serotonin Aggravated Myocardial 
Ischemia and Reperfusion Injury
Myocardial infarction was induced by temporary coro-
nary artery ligation in mice. At baseline serotonin plasma 
levels were low (73.5±8.7 ng/mL), but surged within 
24 hours after 30 minutes of myocardial ischemia with 
subsequent reperfusion in WT mice (153.3±31.3 ng/
mL; Figure 1A). In blood, serotonin is stored in plate-
lets at millimolar concentrations and is quickly released 
on their activation, which raises serotonin levels from 
nanomolar (in resting plasma) to micromolar concen-
trations (locally in vivo during thrombosis or inflamma-
tion or in vitro in serum preparations).19,20 Tryptophan 
hydroxylase-1–deficient mice (Tph1−/−) are devoid of 
serotonin in blood, and platelets in particular, while ser-
otonin levels in the central nervous system remain unaf-
fected21 (Figure 1A). When Tph1–/– mice were subjected 
to myocardial ischemia with reperfusion, the infarct size 
was significantly reduced by about 35% compared to 
WT controls (36.4±2.4 versus 55.3±3.2% area at risk 
[AAR]; Figure 1B). In line, echocardiography document-
ed less compromised left ventricular (LV) function early 
on and up to 3 weeks post-MI in Tph1–/– mice (~ 40% 
relative preservation of ejection fraction on d2 and 25% 
improved ejection fraction on d7; Figure 1C; Table III in 
online-only Data Supplement). Moreover, inflammatory 
gene expression of MPO (-65.3±19%), tumor necrosis 
factor-α (TNFα; -59.8±16%), and chemokine keratino-
cyte chemoattractant (-48.5±16%) were reduced in the 
infarcts of Tph1–/– mice. The changes were considered 
significant between groups for MPO and TNFα after 
multiple comparisons testing (Figure 1D; Table I in the 
online-only Data Supplement).
Platelet Serotonin Promoted Myocardial 
Neutrophil Infiltration
Neutrophils have previously been recognized as decisive 
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firmed that neutrophils were the most abundant im-
mune cell population within the left ventricle at 24 hours 
post-infarction (44.8±5.4% of leukocytes in WT con-
trols; Figure 2A). Coinciding with reduced infarct size, 
we found fewer neutrophils within the infarcted tissue 
of Tph1–/– mice as compared to WT controls (13.9±1.5 
versus 27.1±2.7 per mm2 infarct area; Figure 2A and 
2B) while their numbers in the blood, spleen, and bone 
marrow did not differ significantly (Figure 2C). Mono-
cyte counts in the infarct, blood, spleen and bone mar-
row were similar between the groups, pointing toward 
a mechanism that influenced neutrophil infiltration, in 
particular (Figure 2A; Figure I in the online-only Data 
Supplement). Indeed, neutrophil depletion protected 
WT mice from myocardial reperfusion injury (39.2±3 
versus 53.2±4.2% AAR IgG treatment) to a similar ex-
tent as serotonin depletion in Tph1–/– mice, and did not 
alter the effects seen in Tph1–/– mice (Figure 2D and 2E; 
Figure IF in the online-only Data Supplement). When 
hearts from WT and Tph1–/– mice were perfused ex vivo 
in the absence of circulating leukocytes and subjected 
to myocardial ischemia with reperfusion, both loss in 
cardiac function and cardiomyocyte viability were com-
parable in both groups (Figure II in the online-only Data 
Supplement). We concluded that the deleterious ef-
fects of platelet serotonin on myocardial reperfusion 
injury mainly depended on neutrophil influx.
Serotonin Increased Integrin Alpha-M 
Surface Expression on Neutrophils
Platelets can directly interact with neutrophils to form 
complexes.23,24 PNC formation in blood and heart dou-




Figure 1. Myocardial reperfusion injury is dampened in Tph1−/− mice.  
A, Plasma serotonin levels in wild-type (WT; red) and Tph1−/− (blue) before, and 6, 24, and 48 hours after myocardial infarction with reperfusion. Values in sham (tho-
racotomy was performed without ligation of the left anterior descending [LAD]) operated WT mice are shown in grey. Results are presented as mean±SEM, *P<0.05 
indicates significant changes compared with time point 0 hours within groups, §P<0.05 indicates significant changes between WT and Tph1−/− mice, and ‡P<0.05 
between WT and Sham, 2-way ANOVA with Bonferroni multiple comparisons testing, n≥6 independent animals per group and time point. B, Representative images 
of heart sections of WT and Tph1−/− mice after 30 minutes of LAD ligation with 24 hours of reperfusion at increasing distance from the site of ligation. The infarct area 
(white tissue) is circumscribed in yellow and quantified as percentage of area at risk (AAR; nonblue tissue). The AAR is presented as percentage of the entire heart 
section. Viable tissue within the AAR was stained in red. Results are presented as mean±SEM. *P<0.05, Student t test, n≥10 per group, WT (red) and Tph1−/− (blue). C, 
Time course of fractional shortening (FS) and left ventricular ejection fraction of WT and Tph1−/− mice recorded under baseline (d0) conditions and repetitively over 3 
weeks (at day 2, 7, and 21) after myocardial infarction with reperfusion. Results are presented as mean±SEM. *§P<0.05, * indicates significant changes between differ-
ent genotypes, § indicates significance compared with d0 within groups. Two-way repeated measures ANOVA with Bonferroni multiple comparison testing, n=8 per 
group, WT (red) and Tph1−/− (blue). D, Expression of pro- and anti-inflammatory target genes in homogenized heart tissue after ischemia/reperfusion injury. Results are 
presented in a heat map depicting 2−▵Ct values, n=9 per group, each column represents 1 WT or Tph1−/− mouse. P values were derived from comparison of respective 
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injury but remained low in Tph1–/– mice (41.3±5.8 ver-
sus 24.2±3.1% blood neutrophils; 10.3±1.2 versus 
5.5±0.7%MI tissue neutrophils; Figure  3A and 3B). 
Platelet monocyte complex formation however was sim-
ilar in both groups (Figure IE in the online-only Data Sup-
plement). Interestingly, surface expression of CD11b on 
neutrophils was significantly increased in WT mice com-
pared to Tph1–/– mice, with CD11b (integrin alpha-M, 
α-subunit of Mac-1) known to mediate leukocyte ad-
hesion to endothelial cells and platelets19,25 (Figure 3C; 
Figure IIIA in the online-only Data Supplement). Other 





Figure 2. Reduced neutrophil accumulation in hearts of Tph1−/− mice after myocardial ischemia/reperfusion (I/R) injury.  
A, Representative flow cytometric dot plots of digested cardiac tissues of wild-type (WT) and Tph1−/− mice 24 hours after myocardial ischemia and subsequent 
reperfusion (left). Quantification of neutrophils, monocytes, and macrophages in cardiac tissue of WT (red) and Tph1−/− (blue) mice 24 hours after myocardial I/R 
injury (right). Results are presented as mean percent of CD45.2+ leukocytes ± SEM, *P<0.05, Student t test, n≥7 per group. B, Representative immunohistology 
of myocardial infarct tissue. Ly6G+ neutrophils are stained in red (left panels) and quantified per mm2 tissue section of WT (red) and Tph1−/− (blue) mice. Results are 
presented as mean±SEM, *P<0.05, Student t test, n≥9 per group. C, Neutrophil counts of WT (red) and Tph1−/− (blue) mice in blood before, and in blood, spleen, 
and bone marrow after myocardial I/R injury. Results are presented as mean±SEM, n.s. (not significant), 2-way ANOVA with Bonferroni multiple comparison testing 
was used for blood samples, Student t test was used for spleen and bone marrow, n=6 independent animals per group and time point. D, Quantification of blood 
neutrophils after depletion with anti-Ly6G versus IgG control. Results are presented as mean±SEM. *P<0.05, 2-way ANOVA with Bonferroni multiple comparison 
testing, n=6 per group, WT (red) and Tph1−/− (blue). E, Representative images of heart sections of WT and Tph1−/− mice after 30 minutes of left anterior descending 
ligation followed by 24 hours of reperfusion at increasing distance from the site of ligation. The infarct area (white tissue) is circumscribed in yellow and quantified 
as percentage of area at risk (AAR; nonblue tissue). The AAR is presented as percentage of the entire heart section. Viable tissue within the AAR was stained in 
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of LFA-1), L-selectin (CD62L), P-selectin glycoprotein li-
gand 1 (PSGL-1), and chemokine receptors remained 
largely unaffected (Figure 3C; Figure IIIA in the online-
only Data Supplement). Indeed, intravital microscopy of 
TNFα stimulated mesenteric venules revealed reduced 
numbers of adherent leukocytes in Tph1–/– mice (Fig-
ure IVA in the online-only Data Supplement) an effect 
limited to 5-HT mediated effects on neutrophils (Figure 
IVB in the online-only Data Supplement) while their mi-
gratory capacity appeared normal in vitro (Figure IVC 
in the online-only Data Supplement). Platelet surface 
marker expression in PNCs was similar in both groups 
(Figure  3D). Circulating platelets in Tph1–/– mice ex-
pressed lower levels of activated GPIIb/IIIa and GPV after 
myocardial infarction (Figure IIIB in the online-only Data 
Supplement), while in vitro stimulation of platelets with 
serotonin in the absence of costimulators had no signifi-
cant effects on platelet activation marker expression and 
integrity (Figure VC in the online-only Data Supplement 
), supporting serotonin´s role as a platelet coactivator 
that does not induce classical platelet activation without 
additional stimuli.26 In contrast, incubating blood neu-
trophils with serotonin selectively raised CD11b surface 
expression by approximately 40% (Figure 4A; Figure VA 
in the online-only Data Supplement).
Serotonin-Induced Degranulation of 
Neutrophils
Neutrophil stimulation with serotonin increased CD11b 
surface expression both in WT and Tph1–/– mice, thereby 
normalizing CD11b levels in the knockout animals (Fig-
ure 4A). In contrast, CD11b surface expression in mono-
cytes was similar in both groups before and after incu-
bation with serotonin (Figure 4B). These observations 
pointed to a neutrophil-specific and inducible seroto-
nin effect. Identification of several serotonin receptors, 
most notably subtype 4 and 7, on isolated neutrophils 
suggested that neutrophils were able to respond to ser-
otonin, directly (Figure  4C; Table II in the online-only 
Data Supplement). Unlike monocytes, neutrophils carry 
intracellular granules that are shuttled to the surface 
A B
C D
Figure 3. Platelet neutrophil complex formation is reduced in Tph1−/− mice after reperfusion injury.  
A, Representative dot plots displaying platelet neutrophil complexes (PNC) in blood of wild type (WT) and Tph1−/− mice (left panel). PNCs were quantified before 
and after 24 hours of reperfusion (right panel). Results are presented as mean±SEM, *P<0.05 comparing time points. §P<0,05 comparing groups, 2-way ANOVA 
with Bonferroni multiple comparison testing, n≥10 independent animals per group and time point, WT (red) and Tph1−/− (blue). B, Representative dot plots 
and quantification of PNCs within the AAR of WT (red) and Tph1−/− (blue) mice at 24 hours after myocardial ischemia with reperfusion. Results are presented as 
mean±SEM. *P<0.05, Student t test, n≥7 per group. C, Quantification of CD11b, CD11a, CXCR-2, CD62L, and PSGL-1 surface expression in PNC of WT (red) and 
Tph1−/− (blue) mice 24 hours after myocardial ischemia/reperfusion (I/R) injury. Results are presented as normalized mean±SEM. *P<0.05, Student t test, n=10 per 
group. D, Activated GPIIb/IIIa, GPV, GPVI, and P-selectin platelet marker expression in PNC of WT and Tph1−/− mice 24 hours after myocardial I/R injury. Results are 
presented as normalized mean±SEM. n.s. (not significant), Student t test, n=10 per group. Bar graphs are accompanied by representative histograms of mean fluo-
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on stimulation. CD11b, but not CD11a, is stored in se-
cretory granules alongside other neutrophil mediators 
such as lipocalin-2 and MPO.27 Flow cytometric stain-
ing after membrane permeabilization documented that 
most of the neutrophil’s CD11b was stored intracellu-
larly. Tph1–/– mice showed similar total CD11b protein 
levels to those in wild type mice while CD11b surface 
expression was relatively reduced by trend (Figure 4D). 
These data suggested that serotonin engaged in gran-
ule release in neutrophils. Consequently, stimulation of 
cultured blood neutrophils with serotonin did not only 
increase CD11b surface expression but also lipocalin-2 
and MPO levels in the supernatants (Figure  4E). We 
also detected a release of hydrogen peroxide (H2O2), a 
highly reactive oxidative burst product, on stimulation 
(Figure 4E). Conversely, inhibition of granule release by 
treatment with protein transport inhibitors brefeldin 
A and monensin abolished the rise of CD11b in wild 
type and Tph1–/– mice (Figure 4A). Comparing electron 
microscopic images of neutrophils before and after 
stimulation with serotonin, we were able to visualize 
and quantify the disposal of azurophilic (45.9±3.9 ver-
sus 35.6±2.3) and specific granules (64.1±3.5 versus 
35.2±4.8; Figure 4F). Taken together, our data indicate 
a critical role for platelet serotonin in the regulation of 
neutrophil degranulation.
Platelet Serotonin Depletion by 
Fluoxetine Protected From Myocardial 
Ischemia Reperfusion Injury
We wondered whether we could phenocopy our obser-
vations made in Tph1–/– mice by treating WT mice with 




Figure 4. Serotonin mediates degranulation of neutrophils in vitro.  
A, Representative dot plots displaying uncomplexed (free) neutrophils (SSChigh, Ly6G+, CD41−) in blood (left). Quantification of neutrophil CD11b expression in 
wild-type (WT; red) and Tph1−/− (blue) mice on stimulation with PBS (control) or 100 µmol/L serotonin coincubated with dimethyl sulfoxide or GolgiStop/Plug rea-
gent (right). Results are presented as mean±SEM. *P<0.05, 2-way ANOVA with Bonferroni test, n≥12 per group. B, Dot plots of uncomplexed (free) monocytes 
(SSClow, CD11b+, CD41−) in blood (left) and quantification of CD11b expression after serotonin or PBS treatment (right). Results are presented as mean±SEM. 
*P<0.05, 2-way ANOVA with Bonferroni test, n≥12 per group, WT (red) and Tph1−/− (blue). C, Expression of different serotonin receptors in isolated neutrophils in 
WT (red) and Tph1−/− (blue) mice. Results are presented as normalized mean±SEM. n.s. (not significant), Student t test, n=5 per group. D, Intracellular expression 
of CD11b in neutrophils compared to matched surface expression in blood of WT (red) and Tph1−/− (blue) mice. Results are presented as mean±SEM normalized to 
WT surface staining. *P<0.05 denotes significant changes between surface and intracellular staining, 2-way ANOVA for repeated measures with Bonferroni mul-
tiple comparison testing, n=5 per group. E, Plasma concentration of lipocalin-2,MPO, and H2O2 in WT (red) and Tph1
−/− (blue) blood after stimulation with either 
serotonin or PBS. Results are presented as normalized mean±SEM. *P<0.05, paired Student t test, n=9 per group. F, Electron microscopic images of neutrophils 
after treatment with serotonin or PBS (top). Quantification of azurophilic granules (AG) and specific granules (SG) per cross section after stimulation with serotonin 
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etine (Flx) for 3 weeks. The long-term SSRI treatment 
(mimicking SSRI treatment of patients with depression) 
resulted in a near complete depletion of serotonin stores 
in platelets (Figure 5A). Consequently, plasma serotonin 
remained at baseline in Flx treated mice even after myo-
cardial ischemia with reperfusion (Figure 5B). Serotonin 
depletion resulted in a decreased PNC frequency with 
lower surface expression of CD11b on neutrophils, and 
reduced plasma MPO levels post MI (Figure 5D and 5E). 
Surface expression of CD11a and other adhesion mol-
ecules did not change and circulating platelets showed 
a decrease of activation markers with SSRI treatment 
similar to that observed in Tph1–/– mice (Figure VIA and 
VIB in the online-only Data Supplement). Lastly, infarct 
size (39.9±1.9 versus 56.4±2.8% AAR) and heart func-
tion (20.2±0.7 versus 12.6±0.5% FS) improved with 
SSRI treatment (Figure 5F and 5G). P2Y12 inhibitors are 
routinely used in the acute treatment of MI and have 
been described to limit myocardial ischemia and re-
perfusion injury.28,29 We tested whether this protection 
was at least partly mediated by preventing the release 
of serotonin from platelets during myocardial infarc-
tion (Figure VIIA in the online-only Data Supplement). 






Figure 5. Pharmacological platelet serotonin depletion protects from myocardial ischemia-reperfusion injury.  
A, Three-week administration of fluoxetine (Flx) depletes platelet dense granule serotonin storage (indirectly assessed by freshly provoked serum). Results are 
presented as mean±SEM. *P<0.05, Student t test, n=7 per vehicle (red) or Flx (white) treatment. B, Plasma serotonin levels in vehicle (red) and Flx (white) before, 
and 24 hours after myocardial infarction with reperfusion. Results are presented as mean±SEM. *P<0.05 comparing time points within groups, §P<0.05 compar-
ing groups, 2-way ANOVA with Bonferroni multiple comparison testing, n=7 independent animals per treatment and time point. C, Representative dot plots of 
circulating platelet neutrophil complexes (PNC) in vehicle (red) and Flx (white)-treated mice (left) and quantification before and after 24 hours after myocardial 
ischemia/reperfusion (I/R) injury. Results are presented as mean±SEM. P<0.05 comparing time points within groups, *§P<0.05 comparing groups, 2-way ANOVA 
with Bonferroni multiple comparison testing, n=7 independent animals per treatment and time point. D, Quantification of CD11b surface expression in PNC 
and (E) plasma MPO levels of vehicle (red) and Flx (white)-treated mice 24 hours after myocardial ischemia and reperfusion. Results are presented as normalized 
mean±SEM. *P<0.05, Student t test, n=7 per group. F, Representative images of heart sections of vehicle and fluoxetine treated mice after 30 minutes of left an-
terior descending ligation with 24 hours of reperfusion. Infarcted areal (white tissue) is circumscribed in yellow and quantified as percentage of area at risk (AAR; 
nonblue tissue). The AAR is presented as percentage of the entire heart section. Viable tissue within the AAR is stained in red. Results are presented as mean±SEM. 
*P<0.05, Student t test, n=7 per vehicle (red) and Flx (white) treatment. G, Left ventricular fractional shortening in vehicle (red) and Flx (white) treated mice after 
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diphosphate (ADP) stimulated platelet aggregation, ti-
cagrelor administration blocked ADP effects completely 
and blunted platelet P-selectin externalization both in 
Flx and vehicle treated mice (Figure VIIB and VIIE in the 
online-only Data Supplement). Serotonin release, how-
ever, remained unaffected by ticagrelor (Figure VIIC in 
the online-only Data Supplement). In accord, ADP and 
many other platelet agonists except for thrombin and 
LPS failed to stimulated 5-HT release from platelets in 
vitro (Figure VIID in the online-only Data Supplement). 
In neutrophils, Flx or ticagrelor alone reduced CD11b 
surface expression to a similar extent. The combination 
of both drugs, however, reduced neutrophil CD11b ex-
pression and PNC formation by an additional 30% to 
50% (Figure VIIF and VIIG in the online-only Data Sup-
plement). Consequently, the complementary blockade 
of ADP-dependent platelet activation and serotonin re-
lease proved to reduce the infarct size even more effec-
tively than either drug alone (Figure VIIH in the online-
only Data Supplement).
Plasma Serotonin Correlated With the 
Neutrophil Release of CD11b and MPO in 
ACS Patients
In accord with our findings in mice, human neutrophils 
showed strong upregulation of CD11b surface expres-
sion and elevated plasma MPO levels on stimulation 
with serotonin in vitro. These effects were reversed by 
blocking the 5HT receptor subtype 7, specifically (Fig-
ure 6A), and by vesicle transport inhibition (Figure VIIIA 
in the online-only Data Supplement). CD11b expres-
sion on neutrophils gradually increased within minutes 
of incubation with serotonin (Figure VIIIB in the online-
only Data Supplement). In contrast, CD11b expression 
on human monocytes as well as CD11a expression on 
either cell type did not change in response to seroto-
nin (Figure VIIC in the online-only Data Supplement). 
In patients with acute coronary syndrome (see Table IV 
in the online-only Data Supplement for demographics), 
CD11b surface expression and plasmatic MPO concen-
tration strongly correlated with serotonin levels in plasma 
(Pearson r=0.846, r=0.6606, and r=0.516, respectively), 
while no significant correlations were observed for 
CD11a, CD62L, PSGL-1, and CXCR2 (Figure 6B through 
6D; Figure VIIID in the online-only Data Supplement). Of 
note, all patients studied had been treated with aspirin 
plus a P
2Y12 inhibitor for at least 24 hours before blood 
sampling. Conversely, in patients with depression, long-
term SRI use suppressed plasma serotonin levels, and 
reduced neutrophil CD11b expression significantly and 
MPO levels by trend (Figure 6E) compared to controls 
(Table V in the online-only Data Supplement). We con-
cluded that activated platelets released serotonin during 
myocardial ischemia and reperfusion injury leading to 
the release of secretory granules containing CD11b and 
MPO in neutrophils. Elevated CD11b surface expression 
supported platelet neutrophil complex formation and 
cell adhesion to the endothelium while MPO aggravated 
inflammation (Figure 7).
Taken together, long-term fluoxetine treatment, an 
inducible model of platelet serotonin depletion in adult 
WT mice, phenocopied Tph1–/– mice that underwent 
temporary LAD ligation with respect to CD11b and 
MPO release and protection from experimental myocar-
dial ischemia and reperfusion injury. Our clinical data 
suggest that similar mechanisms operate in humans.
DISCUSSION
Serotonin is well known as a neurotransmitter and mod-
ulator of vasomotion.30–32 Platelets are the dominant 
store of serotonin outside the nervous system and dis-
charge serotonin on activation. Coronary artery disease 
and myocardial infarction provide a platelet-stimulating 
microenvironment that leads to the release of seroto-
nin from platelets.33 We identified thrombin and TLR4 
ligands, but not ADP, as stimulators of serotonin release. 
In particular, younger patients with coronary artery di-
sease and high serotonin levels are at increased risk for 
future cardiovascular events.34 Mechanistically, serotonin 
was thought to promote platelet aggregation and vaso-
constriction of diseased coronary arteries and influence 
cardiomyocyte function and survival.35,36 Experimental 
studies in animals investigating the role of serotonin in 
myocardial ischemia and reperfusion injury yielded con-
flicting results, which has, to date, prevented a success-
ful translation into clinical studies.33,37 Discrepancies may 
have originated from different experimental setups, dif-
ferent animal models, and most notably, different sero-
tonin receptor antagonists being investigated.
In an early study, the 5-HT2 receptor antagonist 
LY53857 did not influence infarct size after 90 minutes 
of ligation of the left circumflex coronary artery followed 
by 5 hours of reperfusion in living dogs.38 In contrast, 
the combined Ca2+ and 5-HT2 receptor antagonist nexo-
pamil reduced infarct size by 55% after 1 hour of LAD 
ligation and 3 hours of reperfusion in living minipigs.39 
While LY53857 rather increased ex vivo reperfusion in-
jury of isolated rat hearts perfused with platelets in an 
experimental setup with 15 minutes global ischemia fol-
lowed by 10 minutes of reperfusion,40 several 5-HT2 re-
ceptor antagonists reduced ex vivo reperfusion injury of 
rat hearts after 25 minutes of ischemia and 30 minutes 
of reperfusion.41 Circulating serotonin levels were signif-
icantly increased after 30 minutes of myocardial ische-
mia in living rabbits, as well as in isolated rabbit hearts, 
and treatment with the 5-HT2A receptor antagonist sar-
pogrelate reduced infarct size by 32% (after 48 hours of 
reperfusion) in a more recent study.33 We report now the 
first study on myocardial reperfusion injury investigating 
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Transient ischemia of ex vivo perfused hearts of 
Tph1–/– mice devoid of peripheral serotonin did not 
affect the loss in cardiac function in the absence of 
circulating cells, while neutrophil depletion in vivo 
completely abolished the platelet serotonin-mediated 
aggravation of reperfusion injury.
Intrigued by these neutrophil-dependent effects, 
we identified platelet-derived serotonin as a potent 
stimulator of neutrophils in vitro and in vivo. We pro-
vided several lines of evidence that serotonin-induced 
degranulation in neutrophils increased the surface ex-
pression of granule-stored CD11b27,42 and the release 
of MPO known to enhance tissue damage in concert 
with reactive oxygen species.13,43 First, we found that 
serotonin elicits CD11b, but not CD11a, surface ex-
pression in neutrophils, but not monocytes, as CD11a 
is not stored in intracellular granules44 and monocytes 
are almost devoid of those. Second, vesicle transport in-
hibition blocked the increase of CD11b surface expres-
sion. Third, electron microscopy of neutrophils directly 
visualized the depletion of intracellular granules on ser-
otonin stimulation. The prompt and gradual increase of 
CD11b surface expression in neutrophils resembled de-
granulation kinetics reported for other granule-derived 
mediators such as MPO, CD66b, lactoferrin, lysozyme, 
gelatinase, and neutrophil gelatinase-associated lipo-
calin.45 Interestingly, the P2Y12 antagonist ticagrelor in-
hibited platelet activation and lowered CD11b surface 
expression on neutrophils as well. However, these in-
hibitory effects were independent from serotonin. Ser-
otonin depletion resulted in an additional reduction in 
CD11b expression. Our data indicate that neutrophil 
degranulation is nonredundantly controlled by several 
stimuli, of which serotonin is being described in this 
work for the first time.
We discovered several serotonin receptor subtypes 
on neutrophils, most prominently 5-HT4 and 5-HT7. 
Neutrophil degranulation depends on intracellular cal-
cium increase that is typically mediated by chemokine/
cytokine-induced G protein–coupled receptor signal-
ing.46 Direct serotonin effects on neutrophil degranu-
lation have not been described before. However, ser-
otonin has been shown to stimulate Ca2+ influx and 
intracellular Ca2+ mobilization in vascular smooth mus-
cle cells both via G protein coupled/IP3-dependent (eg, 
5-HT2 receptor subset) and cAMP/PKA-dependent (eg, 
5-HT4-7 receptor subsets) signaling pathways.
18,47 We 
demonstrated that serotonin stimulated neutrophil de-
granulation via the receptor subtype 7 in humans.
Increased CD11b surface expression renders neu-
trophils more effective in adhering to the activated 
endothelium, the extracellular matrix,7,25 and to plate-
A D
B C
Figure 6. Human neutrophil degranulation is regulated by serotonin.  
A, Supernatant myeloperoxidase (MPO) concentration and surface CD11b expression on human neutrophils after stimulation with 100 µmol/L serotonin or PBS 
with and without addition of specific serotonin receptor antagonist (5HTR4 and 5HTR7). Representative histograms of changes in CD11b expression are shown on 
the right. Results are presented as mean±SEM. *P<0.05, 1-way ANOVA with Tukey t test, n=4 per treatment. B, Correlation of plasma serotonin concentration and 
CD11b (P<0.0001) on blood neutrophils and (C) plasma MPO concentration of patients with acute coronary syndrome. Each point represents an individual patient, 
r=Pearson correlation coefficient. D, Quantification of plasma serotonin and MPO levels and CD11b expression in blood of depressed patients treated with (lime 
green) or without (blue) antidepressants. *P<0.05, Student t test, n=10 per group. n.s. indicates not significant. Dow
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lets, forming complexes.19 Consequently, lack of plate-
let serotonin resulted in reduced numbers of PNC and 
neutrophil deposition in the injured heart. Our findings 
are in line with previous reports suggesting that limiting 
neutrophil influx protected from myocardial reperfusion 
injury.48 Serotonin has further been shown to aggravate 
other neutrophil-dependent inflammatory diseases 
like arthritis, endotoxic shock, asthma, or viral hepa-
titis,11,49,50 but the cellular mechanisms have not been 
completely evaluated.
Finally, we verified that long-term SSRI treatment emp-
tied platelet serotonin stores, providing us with an in-
ducible model of peripheral serotonin deficiency in adult 
mice. Long-term SSRI treatment protected from myocar-
dial reperfusion injury similar to TPH1 deficiency, result-
ing in a comparable reduction in CD11b surface expres-
sion in neutrophils. Intriguingly, SSRI treatment protected 
from myocardial ischemia/reperfusion injury even on top 
of P2Y12 inhibition, which is an essential part of standard 
of care for ACS patients, clinically, and was reported to 
limit myocardial ischemia/reperfusion injury, experimen-
tally in rats and rabbits.28,29 Platelets, our data suggest, 
govern neutrophil responses in serotonin-dependent and 
-independent pathways. Wholesome platelet depletion, 
however, may offset the protection conferred by selec-
tive serotonin depletion and P2Y12 inhibition in exchange 
for bleeding complications and is not a viable option in 
practice.29 We therefore advocate for targeting undesir-
able platelet effects in MI, such as those mediated by 
serotonin, while preserving beneficial ones.
This view is supported by clinical data showing that 
chronic SSRI use was associated with fewer cardiovascular 
events in patients with depression.12 Thus, we extended 
our experimental studies to humans. We confirmed the 
stimulatory effects of serotonin on CD11b surface expres-
sion and MPO release in human neutrophils mediated 
via the 5HT7 receptor. Elevated plasma serotonin levels 
correlated with neutrophil CD11b surface expression 
and MPO plasma levels in patients with acute coronary 
syndrome. Platelet serotonin depletion in noncardiac pa-
tients treated with SSRI for their depression, we showed, 
suppressed CD11b expression and MPO levels.
Thus, we identified a novel mode of platelet-neutro-
phil crosstalk during myocardial ischemia and reperfu-
sion injury that is relevant to humans: platelets secrete 
serotonin to promote degranulation of neutrophils with 
Figure 7. Proposed model of platelet serotonin-neutrophil interactions during myocardial reperfusion injury.  
Serotonin released by platelets triggers the degranulation of neutrophils, subsequently leading to increased CD11b surface expression. This enhances circulating 
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CD11b externalization, and MPO and H2O2 secretion 
(Figure 7). These findings provide a pathomechanistic 
rationale for targeting the formerly unrecognized plate-
let serotonin-neutrophil interactome to ameliorate the 
inflammatory response in myocardial ischemia/reperfu-
sion injury.
ARTICLE INFORMATION
Received January 25, 2018; accepted September 19, 2018.
The online-only Data Supplement is available with this article at https://
www.ahajournals.org/doi/suppl/10.1161/circulationaha.118.033942.
Authors
Maximilian Mauler, PhD; Nadine Herr, MD; Claudia Schoenichen, BSc; Thilo 
Witsch, MD; Timoteo Marchini, PhD; Carmen Härdtner, PhD; Christoph Koent-
ges, PhD; Korbinian Kienle, MSc; Véronique Ollivier, PhD; Maximilian Schell; 
Ludwig Dorner, MD; Christopher Wippel; Daniela Stallmann, BSc; Claus Nor-
mann, MD; Heiko Bugger, MD; Paul Walther, PhD; Dennis Wolf, MD; Ingo 
Ahrens, MD; Tim Lämmermann, PhD; Benoît Ho-Tin-Noé, PhD; Klaus Ley, MD; 
Christoph Bode, MD; Ingo Hilgendorf, MD*; Daniel Duerschmied, MD*
Correspondence
Daniel Duerschmied, MD and Ingo Hilgendorf, MD, Department of Cardiology 
and Angiology I, Heart Center, University of Freiburg, Hugstetter Str. 55, 79106 
Freiburg, Germany. Email daniel.duerschmied@universitaets-herzzentrum.de 
and ingo.hilgendorf@universitaets-herzzentrum.de
Affiliations
Faculty of Biology (M.M., K.K.), Faculty of Medicine (M.M., N.H., C.S., T.W., 
T.M., C.H., C.K., M.S., L.D., C.W., D.S., C.N., H.B., D.W., C.B., I.H., D.D.), De-
partment of Cardiology and Angiology I, Heart Center (M.M., N.H., C.S., T.M., 
C.H., C.K., M.S., L.D., C.W., D.S., H.B., D.W., I.A., C.B., I.H., D.D.), University 
of Freiburg, Germany. Max Planck Institute of Immunobiology and Epigenetics, 
Group Immune Cell Dynamics (K.K., T.L.), Department of Psychiatry, University 
Medical Center Freiburg (C.N.), Germany. INSERM Unit 1148, University Paris 
Diderot (V.O., B.H-T-N.); Laboratory for Vascular Translational Science, Sorbonne 
Paris Cité (V.O., B.H-T-N.), France. Central Facility for Electron Microscopy, Ulm 
University; Ulm, Germany (P.W.). La Jolla Institute for Allergy and Immunology, 
La Jolla, CA (D.W., K.L.).
Acknowledgments
We thank Prof Karlheinz Peter, Baker Heart and Diabetes Institute, Melbourne, 
Australia; Prof Michael Reth, Max Planck Institute for Immunobiology and 
Epigenetics, Freiburg, Germany; and Prof Marco Idzko, Department of Pneu-
mology, Medical Center Freiburg, Germany, for their intellectual support and 
discussion of the data. The authors thank Dr Klaus Kaier and Moritz Hess for 
their assistance with statistical analysis. Prof Denisa D. Wagner, Harvard Medical 
School, Boston, MA, has been a long-standing mentor, supporter, and source 
of ideas for N.H. and D.D.
Sources of Funding
This work was supported by the Deutsche Forschungsgemeinschaft (DFG) DU 
1190/3-1 (D.D.) and HI 1573/2 (I.H.), the National Institutes of Health NIH R01 





 1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 
2007;357:1121–1135. doi: 10.1056/NEJMra071667
 2. Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a 
neglected therapeutic target. J Clin Invest. 2013;123:92–100. doi: 
10.1172/JCI62874
 3. Hausenloy DJ, Botker HE, Engstrom T, Erlinge D, Heusch G, Ibanez B, Klon-
er RA, Ovize M, Yellon DM, Garcia-Dorado D. Targeting reperfusion injury 
in patients with ST-segment elevation myocardial infarction: trials and trib-
ulations. Eur Heart J. 2017;38:935–941. doi: 10.1093/eurheartj/ehw145
 4. Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction 
and strategies of protection beyond reperfusion: a continual challenge. 
Eur Heart J. 2017;38:774–784. doi: 10.1093/eurheartj/ehw224
 5. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of le-
thal myocardial reperfusion injury. Cardiovasc Res. 2004;61:481–497. doi: 
10.1016/j.cardiores.2003.10.011
 6. Horckmans M, Ring L, Duchene J, Santovito D, Schloss MJ, Drechsler M, 
Weber C, Soehnlein O, Steffens S. Neutrophils orchestrate post-myocardi-
al infarction healing by polarizing macrophages towards a reparative phe-
notype. Eur Heart J. 2017;38:187–197. doi: 10.1093/eurheartj/ehw002
 7. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of in-
flammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 
2007;7:678–689. doi: 10.1038/nri2156
 8. Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA. Neutrophil 
rolling, arrest, and transmigration across activated, surface-adherent 
platelets via sequential action of P-selectin and the beta 2-integrin 
CD11b/CD18. Blood. 1996;88:146–157. https://www.ncbi.nlm.nih.gov/
pubmed/8704169. Accessed January 9, 2019.
 9. Zarbock A, Ley K, McEver RP, Hidalgo A. Leukocyte ligands for en-
dothelial selectins: specialized glycoconjugates that mediate roll-
ing and signaling under flow. Blood. 2011;118:6743–6751. doi: 
10.1182/blood-2011-07-343566
 10. Kempf T, Zarbock A, Widera C, Butz S, Stadtmann A, Rossaint J, Bolo-
mini-Vittori M, Korf-Klingebiel M, Napp LC, Hansen B, Kanwischer A, 
Bavendiek U, Beutel G, Hapke M, Sauer MG, Laudanna C, Hogg N, Vest-
weber D, Wollert KC. GDF-15 is an inhibitor of leukocyte integrin acti-
vation required for survival after myocardial infarction in mice. Nat Med. 
2011;17:581–588. doi: 10.1038/nm.2354
 11. Duerschmied D, Suidan GL, Demers M, Herr N, Carbo C, Brill A, Cifuni SM, 
Mauler M, Cicko S, Bader M, Idzko M, Bode C, Wagner DD. Platelet seroto-
nin promotes the recruitment of neutrophils to sites of acute inflammation in 
mice. Blood. 2013;121:1008–1015. doi: 10.1182/blood-2012-06-437392
 12. Sauer WH, Berlin JA, Kimmel SE. Effect of antidepressants and their relative 
affinity for the serotonin transporter on the risk of myocardial infarction. Cir-
culation. 2003;108:32–36. doi: 10.1161/01.CIR.0000079172.43229.CD
 13. Ali M, Pulli B, Courties G, Tricot B, Sebas M, Iwamoto Y, Hilgendorf I, Schob S, 
Dong A, Zheng W, Skoura A, Kalgukar A, Cortes C, Ruggeri R, Swirski FK, 
Nahrendorf M, Buckbinder L, Chen JW. Myeloperoxidase inhibition improves 
ventricular function and remodeling after experimental myocardial infarction. 
JACC Basic Transl Sci. 2016;1:633–643. doi: 10.1016/j.jacbts.2016.09.004
 14. Lindsey ML, Bolli R, Canty JM Jr, Du XJ, Frangogiannis NG, Frantz S, Gour-
die RG, Holmes JW, Jones SP, Kloner RA, Lefer DJ, Liao R, Murphy E, Ping 
P, Przyklenk K, Recchia FA, Schwartz Longacre L, Ripplinger CM, Van Eyk 
JE, Heusch G. Guidelines for experimental models of myocardial ischemia 
and infarction. Am J Physiol Heart Circ Physiol. 2018;314:H812–H838. 
doi: 10.1152/ajpheart.00335.2017
 15. Dürk T, Panther E, Müller T, Sorichter S, Ferrari D, Pizzirani C, Di Virgilio F, 
Myrtek D, Norgauer J, Idzko M. 5-Hydroxytryptamine modulates cytokine 
and chemokine production in LPS-primed human monocytes via stimu-
lation of different 5-HTR subtypes. Int Immunol. 2005;17:599–606. doi: 
10.1093/intimm/dxh242
 16. Pracharová L, Okénková K, Lojek A, Cíz M. Serotonin and its 5-HT(2) re-
ceptor agonist DOI hydrochloride inhibit the oxidative burst in total leu-
kocytes but not in isolated neutrophils. Life Sci. 2010;86:518–523. doi: 
10.1016/j.lfs.2010.02.003
 17. Patocka N, Sharma N, Rashid M, Ribeiro P. Serotonin signaling in Schis-
tosoma mansoni: a serotonin-activated G protein-coupled receptor 
controls parasite movement. PLoS Pathog. 2014;10:e1003878. doi: 
10.1371/journal.ppat.1003878
 18. Okubo M, Satoh Y, Hirakawa M, Sasaki K, Masu K, J McHonde G, Ikeda-
Kurosawa C, Kurosaka D, Saino T. Different effect of serotonin on in-
tracellular calcium ion dynamics in the smooth muscle cells between rat 
posterior ciliary artery and vorticose vein. Biomed Res. 2016;37:101–115. 
doi: 10.2220/biomedres.37.101
 19. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interac-





 http://ahajournals.org by on February 6, 2020
Mauler et al Serotonin Amplifies Myocardial Reperfusion Injury
Circulation. 2019;139:918–931. DOI: 10.1161/CIRCULATIONAHA.118.033942 February 12, 2019 931
ORIGINAL RESEARCH 
ARTICLE
 20. Gros A, Ollivier V, Ho-Tin-Noé B. Platelets in inflammation: regulation of 
leukocyte activities and vascular repair. Front Immunol. 2014;5:678. doi: 
10.3389/fimmu.2014.00678
 21. Walther DJ, Peter JU, Bashammakh S, Hörtnagl H, Voits M, Fink H, Bader 
M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. 
Science. 2003;299:76. doi: 10.1126/science.1078197
 22. Jolly SR, Kane WJ, Hook BG, Abrams GD, Kunkel SL, Lucchesi BR. Reduc-
tion of myocardial infarct size by neutrophil depletion: effect of duration 
of occlusion. Am Heart J. 1986;112:682–690.
 23. Page C, Pitchford S. Neutrophil and platelet complexes and their rele-
vance to neutrophil recruitment and activation. Int Immunopharmacol. 
2013;17:1176–1184. doi: 10.1016/j.intimp.2013.06.004
 24. Mauler M, Seyfert J, Haenel D, Seeba H, Guenther J, Stallmann D, Schoe-
nichen C, Hilgendorf I, Bode C, Ahrens I, Duerschmied D. Platelet-neutrophil 
complex formation-a detailed in vitro analysis of murine and human blood 
samples. J Leukoc Biol. 2016;99:781–789. doi: 10.1189/jlb.3TA0315-082R
 25. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in 
health and inflammation. Nat Rev Immunol. 2013;13:159–175. doi: 
10.1038/nri3399
 26. Vanags DM, Rodgers SE, Duncan EM, Lloyd JV, Bochner F. Potentiation of 
ADP-induced aggregation in human platelet-rich plasma by 5-hydroxy-
tryptamine and adrenaline. Br J Pharmacol. 1992;106:917–923. doi: 
10.1111/j.1476-5381.1992.tb14435.x
 27. Borregaard N, Cowland JB. Granules of the human neutrophilic polymor-
phonuclear leukocyte. Blood. 1997;89:3503–3521. https://www.ncbi.
nlm.nih.gov/pubmed/9160655. Accessed January 9, 2019.
 28. Ye Y, Birnbaum GD, Perez-Polo JR, Nanhwan MK, Nylander S, Birnbaum 
Y. Ticagrelor protects the heart against reperfusion injury and improves 
remodeling after myocardial infarction. Arterioscler Thromb Vasc Biol. 
2015;35:1805–1814. doi: 10.1161/ATVBAHA.115.305655
 29. Cohen MV, Yang XM, White J, Yellon DM, Bell RM, Downey JM. 
Cangrelor-mediated cardioprotection requires platelets and sphingo-
sine phosphorylation. Cardiovasc Drugs Ther. 2016;30:229–232. doi: 
10.1007/s10557-015-6633-2
 30. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev 
Med. 2009;60:355–366. doi: 10.1146/annurev.med.60.042307.110802
 31. Duerschmied D, Bode C. [The role of serotonin in haemostasis]. Hamosta-
seologie. 2009;29:356–359. doi: 10.1055/s-0037-1617140
 32. Watts SW. Oh, the places you’ll go! My many colored serotonin (apologies 
to Dr. Seuss). Am J Physiol Heart Circ Physiol. 2016;311:H1225–H1233. 
doi: 10.1152/ajpheart.00538.2016
 33. Shimizu Y, Minatoguchi S, Hashimoto K, Uno Y, Arai M, Wang N, Chen X, 
Lu C, Takemura G, Shimomura M, Fujiwara T, Fujiwara H. The role of sero-
tonin in ischemic cellular damage and the infarct size-reducing effect of sar-
pogrelate, a 5-hydroxytryptamine-2 receptor blocker, in rabbit hearts. J Am 
Coll Cardiol. 2002;40:1347–1355. doi: 10.1016/S0735-1097(02)02158-7
 34. Vikenes K, Farstad M, Nordrehaug JE. Serotonin is associated with coro-
nary artery disease and cardiac events. Circulation. 1999;100:483–489.
 35. Doggrell SA. The role of 5-HT on the cardiovascular and renal systems 
and the clinical potential of 5-HT modulation. Expert Opin Investig Drugs. 
2003;12:805–823. doi: 10.1517/13543784.12.5.805
 36. Nebigil CG, Etienne N, Messaddeq N, Maroteaux L. Serotonin is 
a novel survival factor of cardiomyocytes: mitochondria as a tar-
get of 5-HT2B receptor signaling. FASEB J. 2003;17:1373–1375. doi: 
10.1096/fj.02-1122fje
 37. Muto T, Usuda H, Yamamura A, Yoshida K, Ohashi A, Mitsui-Saitoh K, 
Sakai J, Sugimoto Y, Mizutani H, Nonogaki T, Hotta Y. Protective effects 
of fluvoxamine against ischemia/reperfusion injury in isolated, perfused 
guinea-pig hearts. Biol Pharm Bull. 2014;37:731–739. doi: 10.1248/bpb.
b13-00552
 38. Simpson PJ, Schelm JA, Jakubowski JA, Smallwood JK. The role of seroto-
nin (5HT2) receptor blockade in myocardial reperfusion injury: effects of 
LY53857 in a canine model of myocardial infarction. J Pharmacol Exp Ther. 
1991;258:979–985.
 39. Hohlfeld T, Braun M, Strobach H, Schrör K. Protection of reperfused ische-
mic pig myocardium by nexopamil, a new combined Ca2+ and serotonin 
antagonist. J Cardiovasc Pharmacol. 1994;23:922–931.
 40. Yang BC, Virmani R, Nichols WW, Mehta JL. Platelets protect against my-
ocardial dysfunction and injury induced by ischemia and reperfusion in 
isolated rat hearts. Circ Res. 1993;72:1181–1190.
 41. Grover GJ, Sargent CA, Dzwonczyk S, Normandin DE, Antonaccio MJ. 
Protective effect of serotonin (5-HT2) receptor antagonists in ischemic rat 
hearts. J Cardiovasc Pharmacol. 1993;22:664–672.
 42. Cowland JB, Borregaard N. Granulopoiesis and granules of human neu-
trophils. Immunol Rev. 2016;273:11–28. doi: 10.1111/imr.12440
 43. Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils and monocytes. 
Blood. 2008;112:935–945. doi: 10.1182/blood-2007-12-077917
 44. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles 
in inflammation. Microbes Infect. 2003;5:1317–1327. doi: 10.1016/j.
micinf.2003.09.008
 45. Naegelen I, Beaume N, Plançon S, Schenten V, Tschirhart EJ, Bréchard 
S. Regulation of neutrophil degranulation and cytokine secretion: 
a novel model approach based on linear fitting. J Immunol Res. 
2015;2015:817038. doi: 10.1155/2015/817038
 46. Lacy P. Mechanisms of degranulation in neutrophils. Allergy Asthma Clin 
Immunol. 2006;2:98–108. doi: 10.1186/1710-1492-2-3-98
 47. Wong DT, Perry KW, Bymaster FP. Case history: the discovery of fluoxe-
tine hydrochloride (Prozac). Nat Rev Drug Discov. 2005;4:764–774. doi: 
10.1038/nrd1821
 48. Arai M, Lefer DJ, So T, DiPaula A, Aversano T, Becker LC. An anti-
CD18 antibody limits infarct size and preserves left ventricular func-
tion in dogs with ischemia and 48-hour reperfusion. J Am Coll Cardiol. 
1996;27:1278–1285. doi: 10.1016/0735-1097(95)00578-1
 49. Lang PA, Contaldo C, Georgiev P, El-Badry AM, Recher M, Kurrer M, Cer-
vantes-Barragan L, Ludewig B, Calzascia T, Bolinger B, Merkler D, Oder-
matt B, Bader M, Graf R, Clavien PA, Hegazy AN, Löhning M, Harris NL, 
Ohashi PS, Hengartner H, Zinkernagel RM, Lang KS. Aggravation of viral 
hepatitis by platelet-derived serotonin. Nat Med. 2008;14:756–761. doi: 
10.1038/nm1780
 50. Cloutier N, Paré A, Farndale RW, Schumacher HR, Nigrovic PA, Lac-





 http://ahajournals.org by on February 6, 2020
